Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Stephan

Showing results (71-80 of 146) with videos related to

Pageof 15
Sort By:
Virology|August 22, 2015
Evolution and function of the HCV NS3 protease in patients with acute hepatitis C and HIV coinfectionJulia Dietz, Thomas Lutz, Gaby Knecht, et al.
The Journal of Antimicrobial Chemotherapy|June 26, 2014
Impact of raltegravir on HIV-1 RNA and DNA forms following initiation of antiretroviral therapy in treatment-naive patientsChristoph Stephan, Hanna-Mari Baldauf, Joanne Barry, et al.
Medical Microbiology and Immunology|July 30, 2016
HIV-1 replication in central nervous system increases over time on only protease inhibitor therapyMaximilian Donath, Timo Wolf, Martin Stürmer, et al.
Lancet (London, England)|December 24, 2014
Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive careTimo Wolf, Gerrit Kann, Stephan Becker, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 6, 2006
Tumor targeting by an aptamerBrian J Hicke, Andrew W Stephens, Ty Gould, et al.
AIDS Patient Care and Stds|April 9, 2021
Reasons for Choice of Antiretroviral Regimens in HIV Patients Presenting Late for Initial Treatment in EuropeGundolf Schuettfort, Alfonso Cabello, Aoife G Cotter, et al.
Communications Medicine|December 2, 2025
Ultra-low level HIV p24 drives immune activation in antiretroviral therapy-treated people living with HIVEnrico Richter, Julia König, Antonia Büning, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|February 17, 2022
[HIV First Diagnoses in Germany in 2014 - A Regional Analysis]Benjamin Thomas Schleenvoigt, Juliane Ankert, Hartmut Stocker, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 15, 2013
Antiviral activity, pharmacokinetics, and safety of the HIV-1 protease inhibitor TMC310911, coadministered with ritonavir, in treatment-naive HIV-1-infected patientsHans-Jürgen Stellbrink, Keikawus Arastéh, Dirk Schürmann, et al.
Journal of Electrocardiology|December 15, 2010
Prevalence and prognostic significance of ECG abnormalities in HIV-infected patients: results from the Strategies for Management of Antiretroviral Therapy studyElsayed Z Soliman, Ronald J Prineas, Mollie P Roediger, et al.
Pageof 15

Showing results (71-80 of 146) with videos related to

Sort By:
Pageof 15
Virology|August 22, 2015
Evolution and function of the HCV NS3 protease in patients with acute hepatitis C and HIV coinfectionJulia Dietz, Thomas Lutz, Gaby Knecht, et al.
The Journal of Antimicrobial Chemotherapy|June 26, 2014
Impact of raltegravir on HIV-1 RNA and DNA forms following initiation of antiretroviral therapy in treatment-naive patientsChristoph Stephan, Hanna-Mari Baldauf, Joanne Barry, et al.
Medical Microbiology and Immunology|July 30, 2016
HIV-1 replication in central nervous system increases over time on only protease inhibitor therapyMaximilian Donath, Timo Wolf, Martin Stürmer, et al.
Lancet (London, England)|December 24, 2014
Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive careTimo Wolf, Gerrit Kann, Stephan Becker, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 6, 2006
Tumor targeting by an aptamerBrian J Hicke, Andrew W Stephens, Ty Gould, et al.
AIDS Patient Care and Stds|April 9, 2021
Reasons for Choice of Antiretroviral Regimens in HIV Patients Presenting Late for Initial Treatment in EuropeGundolf Schuettfort, Alfonso Cabello, Aoife G Cotter, et al.
Communications Medicine|December 2, 2025
Ultra-low level HIV p24 drives immune activation in antiretroviral therapy-treated people living with HIVEnrico Richter, Julia König, Antonia Büning, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|February 17, 2022
[HIV First Diagnoses in Germany in 2014 - A Regional Analysis]Benjamin Thomas Schleenvoigt, Juliane Ankert, Hartmut Stocker, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 15, 2013
Antiviral activity, pharmacokinetics, and safety of the HIV-1 protease inhibitor TMC310911, coadministered with ritonavir, in treatment-naive HIV-1-infected patientsHans-Jürgen Stellbrink, Keikawus Arastéh, Dirk Schürmann, et al.
Journal of Electrocardiology|December 15, 2010
Prevalence and prognostic significance of ECG abnormalities in HIV-infected patients: results from the Strategies for Management of Antiretroviral Therapy studyElsayed Z Soliman, Ronald J Prineas, Mollie P Roediger, et al.
Pageof 15